Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury

Stem Cells

Volumn 26, Issue 5, 2008, Pages 1307-1314

  Carvalho, Adriana B ^a   Quintanilha, Luiz Fernando ^a   Dias, Juliana V ^a   Paredes, Bruno D ^a   Mannheimer, Elida G ^a   Carvalho, Felipe G ^a   Asensi, Karina D ^a   Gutfilen, Bianca ^a   Fonseca, Lea Mirian B ^a   Resende, Celia Maria C ^a   Rezende, Guilherme F M ^a   Takiya, Christina M ^a   De Carvalho, Antonio Carlos Campos ^a   Goldenberg, Regina Coeli Dos Santos ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Bone marrow; Fibrosis; Liver; Mesenchymal stromal cells

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALCOHOL; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; COLLAGEN; PLACEBO; TECHNETIUM 99M; BIOLOGICAL MARKER; TECHNETIUM COMPLEX;

ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CELL REGENERATION; CELL THERAPY; CHRONIC DISEASE; CONTROLLED STUDY; DIET; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION; MESENCHYMAL STEM CELL; MORPHOMETRICS; MULTIPOTENT STEM CELL; NONHUMAN; PHENOTYPE; PORTAL VEIN; RAT; STROMA CELL; TREATMENT FAILURE; ANIMAL; BONE MARROW CELL; CYTOLOGY; FIBROSIS; INJECTION; LIVER DISEASE; LIVER FUNCTION TEST; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; WISTAR RAT;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ANIMALS; BIOLOGICAL MARKERS; BONE MARROW CELLS; CHRONIC DISEASE; COLLAGEN; FEMALE; FIBROSIS; INJECTIONS; LIVER DISEASES; LIVER FUNCTION TESTS; MESENCHYMAL STEM CELLS; MULTIPOTENT STEM CELLS; ORGANOTECHNETIUM COMPOUNDS; PHENOTYPE; RATS; RATS, WISTAR; STROMAL CELLS;

EID: 47949131075     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0941     Document Type: Article

References (49)

1. Desmet VJ. Organizational principles. In: Arias IM, Boyer JL, Chisari FV et al., eds. The liver biology and pathobiology, 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001:3-15.
2. Friedman SL, Schiano TD. Cirrhosis and its sequelae. In: Goldman L, Ausiello D, eds. Cecil textbook of medicine, 22th ed. Philadelphia: Saunders 2004:936-944.
3. Rojkind M, Greenwel P. Pathophysiology of Liver Fibrosis. In: Arias IM, Boyer JL, Chisari FV et al., eds. The liver biology and pathobiology, 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001:721-738.
4. The World Health Report-Deaths by cause, sex and mortality stratum in World Health Organization regions. Available at http://www.who.int/en/. Accessed September 7, 2007.
5. 4 induced liver fibrosis in mice. Hepatology 2004;40:1304-1311.
6. Ishikawa T, Terai S, Urata Y et al. Administration of fibroblast growth factor 2 in combination with bone marrow transplantation synergistically improves carbon-tetrachloride-induced liver fibrosis in mice. Cell Tissue Res 2007;327:463-470.
7. 4-injured rats. J Hepatol 2006;44:742-748.
8. Fang B, Shi M, Liao L et al. Systemic infusion of Flk+ mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation 2004;78:83-88.
9. Popp FC, Slowik P, Eggenhofer E et al. No contribution of multipotent mesenchymal stromal cells to liver regeneration in a rat model of prolonged hepatic injury. STEM CELLS 2007;25:639-645.
10. Abdel Aziz MT, Atta HM, Mahfouz S et al. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem 2007;40:893-899.
11. Reeves PG, Nielsen FH, Fahey Jr GC. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993;123:1939-1951.
12. Gutfilen B, Rossini A, Martins FPP et al. Tc-99m-leukocytes-is it an intracellular labeling? J Clin Lab Immunol 1999;51:1-7.
13. Dolber PC, Spach MS. Conventional and confocal fluorescence microscopy of collagen fibers in the heart. J Histochem Cytochem 1993;41:465-469.
14. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317.
15. Iredale JP, Benyon RC, Pickering J et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998;102:538-549.
16. Issa R, Zhou X, Constandinou CM et al. Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology 2004;126:1795-1808.
17. Iredale JP. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 2007;117:539-548.
18. Zhan Y, Wang Y, Wei L et al. Differentiation of hematopoietic stem cells into hepatocytes in liver fibrosis in rats. Transplant Proc 2006;38:3082-3085.
19. Lagasse E, Connors H, Al-Dhalimy et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000;6:1229-1234.
20. Wang X, Montini E, Al-Dhalimy et al. Kinetics of liver repopulation after bone marrow transplantation. Am J Pathol 2002;161:565-574.
21. Jang YY, Collector MI, Baylin SB et al. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 2004;6:532-539.
22. Wang X, Willenbring H, Akkari Y et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003;422:897-901.
23. Vassilopoulos GP, Wang R, Russel DW et al. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003;422:901-904.
24. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM et al. Fusion of bone-marrow-derived cells with Purkinge neurons, cardiomyocytes and hepatocytes. Nature 2003;425:968-973.
25. Camargo FD, Finegold M, Goodell MA et al. Hematopoietic myelomonocytic cells are the major source of hepatocyte fusion partners. J Clin Invest 2004;113:1266-1270.
26. Wagers AJ, Sherwood RI, Christensen JL et al. Little Evidence for Developmental Plasticity of Adult Hematopoietic Stem Cells. Science 2002;297:2256-2259.
27. Thorgeirsson SS, Grisham JW. Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence. Hepatology 2006;43:2-8.
28. Murry CE, Soonpaa MH, Reinecke H et al. Hematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarction. Nature 2004;428:664-668.
29. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
30. Tropel P, Platet N, Platel JC et al. Functional neuronal differentiation of bone marrow-derived mesenchymal stem cells. STEM CELLS 2006;24:2868-2876.
31. Makino S, Fukuda K, Miyoshi S et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999;103:697-705.
32. Shu S, Wei L, Wang J et al. Hepatic differentiation capability of rat bone marrow-derived mesenchymal stem cells and hematopoietic stem cells. World J Gastroenterol 2004;10:2818-2822.
33. Lange C, Bassler P, Lioznov MV et al. Hepatocytic gene expression in cultured rat mesenchymal stem cells. Transplant Proc 2005;37:276-279.
34. Lange C, Bassler P, Lioznov MV et al. Liver-specific gene expression in mesenchymal stem cells is induced by liver cells. World J Gastroenterol 2005;11:4497-4504.
35. Luk JM, Wang PP, Lee CK et al. Hepatic potential of bone marrow stromal cell: development of in vitro co-culture and intra-portal transplantation models. J Immunol Methods 2005;305:39-47.
36. Quintanilha LF, Mannheimer EG, Carvalho AB et al. Bone marrow cell transplant does not prevent or reverse murine liver cirrhosis. Cell Transplant 2007 (in press).
37. Duffield JS, Forbes SJ, Constandinou CM et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005;115:56-65.
38. Safadi R, Ohta M, Alvarez CE et al. Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterology 2004;127:870-882.
39. Shi Z, Wakil AE, Rockey DC. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci U S A 1997;94:10663-10668.
40. Tomchuck SL, Zwezdaryk KJ, Coffelt SB et al. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. STEM CELLS 2008;26:99-107.
41. Tse WT, Pendleton JD, Beyer WM et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003;75:389-397.
42. Ringdén O, Uzunel M, Rasmusson I et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host-disease. Transplantation 2006;81:1390-1397.
43. Inoue S, Popp FC, Koehl GE et al. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 2006;81:1589-1595.
44. Lian G, Wang C, Teng C et al. Failure of hepatocyte marker-expressing hematopoietic progenitor cells to efficiently convert into hepatocytes in vitro. Exp Hematol 2006;34:348-358.
45. Rountree CB, Wang X, Ge S et al. Bone marrow fails to differentiate into liver epithelium during murine development and regeneration. Hepatology 2007;45:1250-1260.
46. Kanazawa Y, Verma IM. Little evidence of bone marrow-derived hepatocytes in the replacement of injured liver. Proc Natl Acad Sci U S A 2003;100(suppl 1):11850-11853.
47. Sato Y, Araki H, Kato J et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005;106:756-763.
48. Aurich Y, Mueller LP, Aurich H et al. Functional integration of hepatocytes derived from human mesenchymal cells into mouse livers. Gut 2007;56:405-415.
49. Bonzo LV, Ferrero I, Cravanzola C et al. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut 200;57:223-231.